The grade II/III primary cells may tend to lose CNAs or mutations that correlate to good prognosis in gliomas, as IDH mutations and 1p/19q codeletion were frequently found in grade II/III gliomas but absent in primary cells from grade II/III gliomas used in this study and other commonly used glioma cell lines. This evidence concerns the gene IDH1 and central nervous system cancer.